The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.
Molecular Biomarkers in Cancer
Open accessAbstract
Molecular cancer biomarkers are any measurable molecular indicator of risk of cancer, occurrence of cancer, or patient outcome. They may include germline or somatic genetic variants, epigenetic signatures, transcriptional changes, and proteomic signatures. These indicators are based on biomolecules, such as nucleic acids and proteins, that can be detected in samples obtained from tissues through tumor biopsy or, more easily and non-invasively, from blood (or serum or plasma), saliva, buccal swabs, stool, urine, etc. Detection technologies have advanced tremendously over the last decades, including techniques such as next-generation sequencing, nanotechnology, or methods to study circulating tumor DNA/RNA or exosomes. Clinical applications of biomarkers are extensive. They can be used as tools for cancer risk assessment, screening and early detection of cancer, accurate diagnosis, patient prognosis, prediction of response to therapy, and cancer surveillance and monitoring response. Therefore, they can help to optimize making decisions in clinical practice. Moreover, precision oncology is needed for newly developed targeted therapies, as they are functional only in patients with specific cancer genetic mutations, and biomarkers are the tools used for the identification of these subsets of patients. Improvement in the field of cancer biomarkers is, however, needed to overcome the scientific challenge of developing new biomarkers with greater sensitivity, specificity, and positive predictive value.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Zeng, L., Zeng, G., & Ye, Z. (2022) · Applied Bionics and Biomechanics · doi:10.1155/2022/9268206 · Cited by 8
RetractedMutational landscape and significance across 12 major cancer types
Kandoth, C., McLellan, M. D., Vandin, F., Ye, K., Niu, B., Lu, C., Xie, M., Zhang, Q., McMichael, J. F., Wyczalkowski, M. A., et al. (2013) · Nature · doi:10.1038/nature12634 · Cited by 4,419
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer
André, T., Shiu, K.-K., Kim, T. W., Jensen, B. V., Jensen, L. H., Punt, C., Smith, D., Garcia-Carbonero, R., Benavides, M., Gibbs, P., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2017699 · Cited by 3,099
Pan-cancer analysis of whole genomes
The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium, Aaltonen, L. A., Abascal, F., Abeshouse, A., Aburatani, H., Adams, D. J., Agrawal, N., Ahn, K. S., Ahn, S.-M., Aikata, H., et al. (2020) · Nature · doi:10.1038/s41586-020-1969-6 · Cited by 3,064
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Cohen, J. D., Li, L., Wang, Y., Thoburn, C., Afsari, B., Danilova, L., Douville, C., Javed, A. A., Wong, F., Mattox, A., et al. (2018) · Science · doi:10.1126/science.aar3247 · Cited by 2,783
Comprehensive Characterization of Cancer Driver Genes and Mutations
Bailey, M. H., Tokheim, C., Porta-Pardo, E., Sengupta, S., Bertrand, D., Weerasinghe, A., Colaprico, A., Wendl, M. C., Kim, J., Reardon, B., et al. (2018) · Cell · doi:10.1016/j.cell.2018.02.060 · Cited by 2,256
Coleman, R. L., Oza, A. M., Lorusso, D., Aghajanian, C., Oaknin, A., Dean, A., Colombo, N., Weberpals, J. I., Clamp, A., Scambia, G., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32440-6 · Cited by 1,693
Liu, M. C., Oxnard, G. R., Klein, E. A., Swanton, C., Seiden, M. V., Liu, M. C., Oxnard, G. R., Klein, E. A., Smith, D., Richards, D., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.02.011 · Cited by 1,495
Extracellular vesicles in cancer — implications for future improvements in cancer care
Xu, R., Rai, A., Chen, M., Suwakulsiri, W., Greening, D. W., & Simpson, R. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0036-9 · Cited by 1,445
Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Grossman, D. C., Curry, S. J., Owens, D. K., Bibbins-Domingo, K., Caughey, A. B., Davidson, K. W., Doubeni, C. A., Ebell, M., Epling, J. W., et al. (2018) · JAMA · doi:10.1001/jama.2018.3710 · Cited by 1,436
Isolation of Extracellular Vesicles: General Methodologies and Latest Trends
Konoshenko, M. Y., Lekchnov, E. A., Vlassov, A. V., & Laktionov, P. P. (2018) · BioMed Research International · doi:10.1155/2018/8545347 · Cited by 1,243
Imaging biomarker roadmap for cancer studies
O'Connor, J. P. B., Aboagye, E. O., Adams, J. E., Aerts, H. J. W. L., Barrington, S. F., Beer, A. J., Boellaard, R., Bohndiek, S. E., Brady, M., Brown, G., et al. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.162 · Cited by 1,091
Distribution of miRNA expression across human tissues
Ludwig, N., Leidinger, P., Becker, K., Backes, C., Fehlmann, T., Pallasch, C., Rheinheimer, S., Meder, B., Stähler, C., Meese, E., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw116 · Cited by 968
Protein Glycosylation in Cancer
Stowell, S. R., Ju, T., & Cummings, R. D. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040438 · Cited by 873
Henry, N. L., & Hayes, D. F. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.01.010 · Cited by 849
Pathogenic Germline Variants in 10,389 Adult Cancers
Huang, K.-L., Mashl, R. J., Wu, Y., Ritter, D. I., Wang, J., Oh, C., Paczkowska, M., Reynolds, S., Wyczalkowski, M. A., Oak, N., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.039 · Cited by 833
An Evidence‐Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine
Whirl‐Carrillo, M., Huddart, R., Gong, L., Sangkuhl, K., Thorn, C. F., Whaley, R., & Klein, T. E. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2350 · Cited by 810
Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways
Boelens, M. C., Wu, T. J., Nabet, B. Y., Xu, B., Qiu, Y., Yoon, T., Azzam, D. J., Twyman-Saint Victor, C., Wiemann, B. Z., Ishwaran, H., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.051 · Cited by 806
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
Cortés-Ciriano, I., Lee, J. J.-K., Xi, R., Jain, D., Jung, Y. L., Yang, L., Gordenin, D., Klimczak, L. J., Zhang, C.-Z., Pellman, D. S., et al. (2020) · Nature Genetics · doi:10.1038/s41588-019-0576-7 · Cited by 712
Pediatric acute lymphoblastic leukemia
Inaba, H., & Mullighan, C. G. (2020) · Haematologica · doi:10.3324/haematol.2020.247031 · Cited by 696
Eighth edition of the AJCC cancer staging manual: breast cancer
Giuliano, A. E., Edge, S. B., & Hortobagyi, G. N. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6486-6 · Cited by 678
PARP and PARG inhibitors in cancer treatment
Slade, D. (2020) · Genes & Development · doi:10.1101/gad.334516.119 · Cited by 667
Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention
Lennon, A. M., Buchanan, A. H., Kinde, I., Warren, A., Honushefsky, A., Cohain, A. T., Ledbetter, D. H., Sanfilippo, F., Sheridan, K., Rosica, D., et al. (2020) · Science · doi:10.1126/science.abb9601 · Cited by 657
Non-invasive early detection of cancer four years before conventional diagnosis using a blood test
Chen, X., Gole, J., Gore, A., He, Q., Lu, M., Min, J., Yuan, Z., Yang, X., Jiang, Y., Zhang, T., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17316-z · Cited by 628
Poste, G. (2011) · Nature · doi:10.1038/469156a · Cited by 582
Statistical Evaluation of a Biomarker
Ray, P., Manach, Y. L., Riou, B., Houle, T. T., & Warner, D. S. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181d47604 · Cited by 503
Cancer biomarker discovery and validation.
Goossens, N., Nakagawa, S., Sun, X., & Hoshida, Y. (2015) · PubMed · doi:10.3978/j.issn.2218-676x.2015.06.04 · Cited by 503
Exploring miRNA based approaches in cancer diagnostics and therapeutics
Mishra, S., Yadav, T., & Rani, V. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.10.003 · Cited by 493
Allenson, K., Castillo, J., San Lucas, F. A., Scelo, G., Kim, D. U., Bernard, V., Davis, G., Kumar, T., Katz, M., Overman, M. J., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx004 · Cited by 493
Bruch, R., Baaske, J., Chatelle, C., Meirich, M., Madlener, S., Weber, W., Dincer, C., & Urban, G. A. (2019) · Advanced Materials · doi:10.1002/adma.201905311 · Cited by 449
Piccart, M., van 't Veer, L. J., Poncet, C., Lopes Cardozo, J. M. N., Delaloge, S., Pierga, J.-Y., Vuylsteke, P., Brain, E., Vrijaldenhoven, S., Neijenhuis, P. A., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00007-3 · Cited by 369
Liquid Biopsy-Based Biomarkers of Treatment Response and Resistance
Kilgour, E., Rothwell, D. G., Brady, G., & Dive, C. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.012 · Cited by 360
Bradley, R., Braybrooke, J., Gray, R., Hills, R., Liu, Z., Peto, R., Davies, L., Dodwell, D., McGale, P., Pan, H., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00288-6 · Cited by 354
Circular RNAs in body fluids as cancer biomarkers: the new frontier of liquid biopsies
Wang, S., Zhang, K., Tan, S., Xin, J., Yuan, Q., Xu, H., Xu, X., Liang, Q., Christiani, D. C., Wang, M., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-020-01298-z · Cited by 331
EVmiRNA: a database of miRNA profiling in extracellular vesicles
Liu, T., Zhang, Q., Zhang, J., Li, C., Miao, Y.-R., Lei, Q., Li, Q., & Guo, A.-Y. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky985 · Cited by 314
Circular RNA: a novel biomarker and therapeutic target for human cancers
Lei, B., Tian, Z., Fan, W., & Ni, B. (2019) · International Journal of Medical Sciences · doi:10.7150/ijms.28047 · Cited by 313
Liquid biopsies: Potential and challenges
Heidrich, I., Ačkar, L., Mossahebi Mohammadi, P., & Pantel, K. (2021) · International Journal of Cancer · doi:10.1002/ijc.33217 · Cited by 278
Saah, A. J., & Hoover, D. R. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-1-199701010-00026 · Cited by 269
Long Non-coding RNAs in Cancer: Implications for Diagnosis, Prognosis, and Therapy
Qian, Y., Shi, L., & Luo, Z. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.612393 · Cited by 261
Biomarker Discovery and Validation: Statistical Considerations
Ou, F.-S., Michiels, S., Shyr, Y., Adjei, A. A., & Oberg, A. L. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2021.01.1616 · Cited by 258
Larson, M. H., Pan, W., Kim, H. J., Mauntz, R. E., Stuart, S. M., Pimentel, M., Zhou, Y., Knudsgaard, P., Demas, V., Aravanis, A. M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22444-1 · Cited by 255
Proteomics technologies for cancer liquid biopsies
Ding, Z., Wang, N., Ji, N., & Chen, Z.-S. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01526-8 · Cited by 249
Wang, Y., Tong, Z., Zhang, W., Zhang, W., Buzdin, A., Mu, X., Yan, Q., Zhao, X., Chang, H.-H., Duhon, M., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.683419 · Cited by 224
Liquid biopsy: Exosomal microRNAs as novel diagnostic and prognostic biomarkers in cancer
Preethi, K. A., Selvakumar, S. C., Ross, K., Jayaraman, S., Tusubira, D., & Sekar, D. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01525-9 · Cited by 221
Constâncio, V., Nunes, S. P., Henrique, R., & Jerónimo, C. (2020) · Cells · doi:10.3390/cells9030624 · Cited by 211
Synthetic biomarkers: a twenty-first century path to early cancer detection
Kwong, G. A., Ghosh, S., Gamboa, L., Patriotis, C., Srivastava, S., & Bhatia, S. N. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00389-3 · Cited by 209
Malhotra, R., Patel, V., Chikkaveeraiah, B. V., Munge, B. S., Cheong, S. C., Zain, R. B., Abraham, M. T., Dey, D. K., Gutkind, J. S., & Rusling, J. F. (2012) · Analytical Chemistry · doi:10.1021/ac301392g · Cited by 207
He, L., Ping, F., Fan, Z., Zhang, C., Deng, M., Cheng, B., & Xia, J. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109553 · Cited by 205
Herold, T., Rothenberg-Thurley, M., Grunwald, V. V., Janke, H., Goerlich, D., Sauerland, M. C., Konstandin, N. P., Dufour, A., Schneider, S., Neusser, M., et al. (2020) · Leukemia · doi:10.1038/s41375-020-0806-0 · Cited by 192
DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer
Müller, D., & Győrffy, B. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188722 · Cited by 174
Sina, A. A. I., Carrascosa, L. G., Liang, Z., Grewal, Y. S., Wardiana, A., Shiddiky, M. J. A., Gardiner, R. A., Samaratunga, H., Gandhi, M. K., Scott, R. J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07214-w · Cited by 172
Biomarker validation and testing
Hayes, D. F. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2014.10.004 · Cited by 167
Recent development in electrochemical biosensors for cancer biomarkers detection
Hasan, M. R., Ahommed, M. S., Daizy, M., Bacchu, M. S., Ali, M. R., Al-Mamun, M. R., Saad Aly, M. A., Khan, M. Z. H., & Hossain, S. I. (2021) · Biosensors and Bioelectronics: X · doi:10.1016/j.biosx.2021.100075 · Cited by 161
Xun, J., Du, L., Gao, R., Shen, L., Wang, D., Kang, L., Chen, C., Zhang, Z., Zhang, Y., Yue, S., et al. (2021) · Theranostics · doi:10.7150/thno.51864 · Cited by 160
Wang, B., Mao, J., Wang, B.-Y., Wang, L., Wen, H., Xu, L., Fu, J., & Yang, H. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.05.038 · Cited by 155
Cancer genetics, precision prevention and a call to action
Turnbull, C., Sud, A., & Houlston, R. S. (2018) · Nature Genetics · doi:10.1038/s41588-018-0202-0 · Cited by 154
Goodman, C. R., Seagle, B.-L. L., Friedl, T. W. P., Rack, B. K., Látó, K., Fink, V., Cristofanilli, M., Donnelly, E. D., Janni, W., Shahabi, S., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.0163 · Cited by 150
Cancer-associated miRNAs and their therapeutic potential
Inoue, J., & Inazawa, J. (2021) · Journal of Human Genetics · doi:10.1038/s10038-021-00938-6 · Cited by 135
Jou, A. F., Lü, C., Ou, Y., Wang, S., Hsu, S., Willner, I., & Ho, J. A. (2014) · Chemical Science · doi:10.1039/c4sc02104e · Cited by 133
Multiple microRNAs as biomarkers for early breast cancer diagnosis
Jang, J. Y., Kim, Y. M., Kang, K., Kim, K. S., Park, Y., & Kim, C. G. (2020) · Molecular and Clinical Oncology · doi:10.3892/mco.2020.2193 · Cited by 130
Sueta, A., Yamamoto, Y., Tomiguchi, M., Takeshita, T., Yamamoto‐Ibusuki, M., & Iwase, H. (2017) · Oncotarget · doi:10.18632/oncotarget.19482 · Cited by 128
Biomarkers of nucleic acid oxidation – A summary state-of-the-art
Chao, M., Evans, M. D., Hu, C., Ji, Y., Möller, P., Rössner, P., & Cooke, M. S. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101872 · Cited by 123
Scheerens, H., Malong, A., Bassett, K., Boyd, Z. S., Gupta, V., Harris, J. M., Mesick, C. P., Simnett, S., Stevens, H., Gilbert, H., et al. (2017) · Clinical and Translational Science · doi:10.1111/cts.12455 · Cited by 121
Arya, S. K., & Estrela, P. (2018) · Sensors · doi:10.3390/s18072010 · Cited by 120
Stool Microbiota Composition Differs in Patients with Stomach, Colon, and Rectal Neoplasms
Youssef, O., Lahti, L., Kokkola, A., Karla, T., Tikkanen, M., Ehsan, H., Carpelan-Holmström, M. A., Koskensalo, S., Böhling, T., Rautelin, H. I. K., et al. (2018) · Digestive Diseases and Sciences · doi:10.1007/s10620-018-5190-5 · Cited by 119
Self-citationSun, L., Liu, X., Pan, B., Hu, X., Zhu, Y., Su, Y., Guo, Z., Zhang, G., Xu, M., Xu, X., et al. (2019) · Journal of Cancer · doi:10.7150/jca.33022 · Cited by 114
Defining Clinical Utility of Tumor Biomarker Tests: A Clinician's Viewpoint
Hayes, D. F. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.01572 · Cited by 112
Liu, H., Liu, Y., Sun, P., Leng, K., Xu, Y., Mei, L., Han, P., Zhang, B., Yao, K., Li, C., et al. (2020) · Clinical Science · doi:10.1042/cs20191087 · Cited by 105
Progress and Challenges of Predictive Biomarkers for Immune Checkpoint Blockade
Lei, Y., Li, X., Huang, Q., Zheng, X., & Liu, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.617335 · Cited by 100
Urinary Exosomal MicroRNAs as Potential Non-invasive Biomarkers in Breast Cancer Detection
Hirschfeld, M., Rücker, G., Weiß, D., Berner, K., Ritter, A., Jäger, M., & Erbes, T. (2020) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-020-00453-y · Cited by 99
Urinary exosome microRNA signatures as a noninvasive prognostic biomarker for prostate cancer
Shin, S. Y., Park, Y. H., Jung, S., Jang, S., Kim, M. Y., Lee, J. Y., & Chung, Y. (2021) · npj Genomic Medicine · doi:10.1038/s41525-021-00212-w · Cited by 96
Wu, Q., Yu, L., Lin, X., Zheng, Q., Zhang, S., Chen, D., Pan, X., & Huang, Y. (2020) · Cancer Management and Research · doi:10.2147/cmar.s232383 · Cited by 94
Detection Methods and Clinical Applications of Circulating Tumor Cells in Breast Cancer
Zhang, H., Lin, X., Huang, Y., Wang, M., Cen, C., Tang, S., Dique, M. R., Cai, L., Luis, M. A., Smollar, J., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.652253 · Cited by 94
Saliva Based Liquid Biopsies in Head and Neck Cancer: How Far Are We From the Clinic?
Patel, A., Patel, S., Patel, P., & Tanavde, V. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.828434 · Cited by 88
Exosomal hsa-miR-21-5p is a biomarker for breast cancer diagnosis
Liu, M., Mo, F., Song, X., He, Y., Yuan, Y., Yan, J., Yang, Y., Huang, J., & Zhang, S. (2021) · PeerJ · doi:10.7717/peerj.12147 · Cited by 85
Precision Medicine and the Role of Biomarkers of Radiotherapy Response in Breast Cancer
Meehan, J., Gray, M., Martínez-Pérez, C., Kay, C., Pang, L. Y., Fraser, J. A., Poole, A. V., Kunkler, I. H., Langdon, S. P., Argyle, D. J., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00628 · Cited by 83
Oncotype DX Breast Recurrence Score®: A Review of its Use in Early-Stage Breast Cancer
Syed, Y. Y. (2020) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-020-00482-7 · Cited by 83
Application of pharmacogenetics in oncology
Miteva-Marcheva, N., Ivanov, H. Y., Dimitrov, D. K., & Stoyanova, V. K. (2020) · Biomarker Research · doi:10.1186/s40364-020-00213-4 · Cited by 81
Clinical trials for predictive medicine: new challenges and paradigms
Simon, R. (2010) · Clinical Trials · doi:10.1177/1740774510366454 · Cited by 80
Establishing mechanisms affecting the individual response to ionizing radiation
Averbeck, D., Candéias, S. M., Chandna, S., Foray, N., Friedl, A. A., Haghdoost, S., Jeggo, P. A., Lumniczky, K., Paris, F., Quintens, R., et al. (2019) · International Journal of Radiation Biology · doi:10.1080/09553002.2019.1704908 · Cited by 78
Chu, Y., Gao, Y., Tang, W., Qiang, L., Han, Y., Gao, J., Zhang, Y., Liu, H., & Han, L. G. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.0c04896 · Cited by 77
Tumor-Derived Exosomal miRNAs as Diagnostic Biomarkers in Non-Small Cell Lung Cancer
Zhang, Z., Tang, Y., Song, X., Xie, L., Zhao, S., & Song, X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.560025 · Cited by 76
EVAtlas: a comprehensive database for ncRNA expression in human extracellular vesicles
Liu, C., Xie, G., Miao, Y., Xia, M., Wang, Y., Lei, Q., Zhang, Q., & Guo, A. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab668 · Cited by 76
Batis, N., Brooks, J. M., Payne, K. F. B., Sharma, N., Nankivell, P., & Mehanna, H. M. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113854 · Cited by 75
Impact of Oncotype DX testing on ER+ breast cancer treatment and survival in the first decade of use
Schaafsma, E., Zhang, B., Schaafsma, M., Tong, C.-Y., Zhang, L., & Cheng, C. (2021) · Breast Cancer Research · doi:10.1186/s13058-021-01453-4 · Cited by 74
Mass spectrometry based proteomics and metabolomics in personalized oncology
Kowalczyk, T., Ciborowski, M., Kiśluk, J., Kretowski, A. J., & Barbas, C. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165690 · Cited by 70
Wang, X., Qian, T., Bao, S., Zhao, H., Chen, H., Xing, Z., Li, Y., Zhang, M., Meng, X., Wang, J., et al. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13029 · Cited by 69
Zhang, Y., & Xu, H. (2020) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23237 · Cited by 68
Kulkarni, B., Gondaliya, P., Kirave, P., Rawal, R., Jain, A. K., Garg, R., & Kalia, K. (2020) · Oncotarget · doi:10.18632/oncotarget.27557 · Cited by 68
Guo, T., Wang, Y., Jia, J., Mao, X., Stankiewicz, E., Scandura, G., Burke, E., Xu, L., Marzec, J., Davies, C. R., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.602493 · Cited by 68
Plasma exosomal miR-125a-5p and miR-141-5p as non-invasive biomarkers for prostate cancer
LI, W., Dong, Y., Wang, K., DENG, Z., Zhang, W., & SHEN, H. F. (2020) · Neoplasma · doi:10.4149/neo_2020_191130n1234 · Cited by 67
Identification of Urinary Exosomal miRNAs for the Non-Invasive Diagnosis of Prostate Cancer
Li, Z., Li, L.-X., Diao, Y., Wang, J., Ye, Y., & Hao, X. (2021) · Cancer Management and Research · doi:10.2147/cmar.s272140 · Cited by 67
Kim, D. H., Park, H., Choi, Y. J., Kang, M. H., Kim, T.-K., Pack, C., Choi, C., Lee, J. C., & Rho, J. K. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04024-9 · Cited by 67
Urinary exosomal microRNA profiling in intermediate-risk prostate cancer
Kim, M. Y., Shin, H., Moon, H. W., Park, Y. H., Park, J., & Lee, J. Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-86785-z · Cited by 64
Plasma Exosomal miRNA-139-3p is a Novel Biomarker of Colorectal Cancer
Liu, W., Yang, D., Chen, L., Liu, Q., Wang, W., Yang, Z., Shang, A., Quan, W., & Li, D. (2020) · Journal of Cancer · doi:10.7150/jca.45548 · Cited by 62
Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing
Terraf, P., Pareja, F. G., Brown, D. N., Ceyhan‐Birsoy, O., Misyura, M., Rana, S., O'Reilly, E. M., Carlo, M. I., Aghajanian, C. A., Liu, Y. L., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.01.006 · Cited by 61
He, T., Guo, X., Li, X., Liao, C., Wang, X., & He, K. (2021) · Journal of Oncology · doi:10.1155/2021/5547911 · Cited by 58
Cacheux, J., Bancaud, A., Leïchlé, T., & Cordelier, P. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00815 · Cited by 57
Elevated exosome-derived miRNAs predict osimertinib resistance in non-small cell lung cancer
Li, X., Chen, C., Wang, Z., Liu, J., Sun, W., Shen, K., Lv, Y., Zhu, S., Zhan, P., Lv, T., et al. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02075-8 · Cited by 56
Sarhadi, V. K., Lahti, L., Saberi, F., Youssef, O., Kokkola, A., Karla, T., Tikkanen, M., Rautelin, H. I. K., Puolakkainen, P. A., Salehi, R., et al. (2020) · Anticancer Research · doi:10.21873/anticanres.14074 · Cited by 54
Self-citationDingerdissen, H., Bastian, F., Vijay‐Shanker, K., Robinson‐Rechavi, M., Bell, A. L., Gogate, N., Gupta, S., Holmes, E., Kahsay, R., Keeney, J., et al. (2020) · JCO Clinical Cancer Informatics · doi:10.1200/cci.19.00117 · Cited by 54
Circulating Exosomal miR-96 as a Novel Biomarker for Radioresistant Non-Small-Cell Lung Cancer
Zheng, Q., Ding, H., Wang, L., Yan, Y., Wan, Y., Yi, Y., Tao, L., & Zhu, C. (2021) · Journal of Oncology · doi:10.1155/2021/5893981 · Cited by 54
Integrating Molecular Biomarker Inputs Into Development and Use of Clinical Cancer Therapeutics
Louie, A. D., Huntington, K. E., Carlsen, L., Zhou, L., & El‐Deiry, W. S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.747194 · Cited by 54
Chi, Z., Wu, Y., Chen, L., Yang, H., Khan, M. R., Busquets, R., Huang, N., Lin, X., Deng, R., Yang, W., et al. (2022) · Analytica Chimica Acta · doi:10.1016/j.aca.2022.339763 · Cited by 50
Todorova, V. K., Byrum, S. D., Gies, A. J., Haynie, C., Smith, H. R., Reyna, N. S., & Makhoul, I. (2022) · Current Oncology · doi:10.3390/curroncol29020055 · Cited by 49
New tools for old drugs: Functional genetic screens to optimize current chemotherapy
Gerhards, N. M., & Rottenberg, S. (2018) · Drug Resistance Updates · doi:10.1016/j.drup.2018.01.001 · Cited by 47
Biomarkers: Portents of malignancy
Brower, V. (2011) · Nature · doi:10.1038/471s19a · Cited by 46
Bustos, M. A., Groß, R., Rahimzadeh, N., Cole, H. R., Tran, L. T., Tran, K. D., Takeshima, L., Stern, S. L., O'Day, S. J., & Hoon, D. S. �. (2020) · Cancers · doi:10.3390/cancers12113361 · Cited by 46
Handa, T., Kuroha, M., Nagai, H., Shimoyama, Y., Naito, T., Moroi, R., Kanazawa, Y., Shiga, H., Kakuta, Y., Kinouchi, Y., et al. (2021) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000356 · Cited by 46
Shi, Y., Zhuang, Y., Zhang, J., Chen, M., & Wu, S. (2021) · Tissue and Cell · doi:10.1016/j.tice.2021.101499 · Cited by 44
miR-425-5p as an exosomal biomarker for metastatic prostate cancer
Rode, M. P., Silva, A. H., Cisilotto, J., Rosolen, D., & Creczynski‐Pasa, T. B. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110113 · Cited by 44
Circulating miRNAs as biomarkers in diffuse large B-cell lymphoma: a systematic review
López-Santillán, M., Larrabeiti-Etxebarria, A., Arzuaga‐Méndez, J., López-López, E., & García‐Orad, Á. (2018) · Oncotarget · doi:10.18632/oncotarget.25230 · Cited by 43
Entrapment of Prostate Cancer Circulating Tumor Cells with a Sequential Size-Based Microfluidic Chip
Ren, X., Foster, B. M., Ghassemi, P., Strobl, J. S., Kerr, B. A., & Agah, M. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b01134 · Cited by 43
Does biomarker use in oncology improve clinical trial failure risk? A large‐scale analysis
Parker, J. L., Kuzulugil, S. S., Pereverzev, K., Mac, S., Lopes, G. D. L., Jr., Shah, Z., Weerasinghe, A., Rubinger, D. A., Falconi, A., Bener, A., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.3732 · Cited by 42
Li, S., Zhang, M., Xu, F. H., Wang, Y., & Leng, D. (2021) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_280_21 · Cited by 42
Microbiota Alterations and Their Association with Oncogenomic Changes in Pancreatic Cancer Patients
Sammallahti, H., Kokkola, A., Rezasoltani, S., Ghanbari, R., Aghdaei, H. A., Knuutila, S., Puolakkainen, P. A., & Sarhadi, V. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312978 · Cited by 42
Self-citationVadla, G. P., Daghat, B., Patterson, N., Ahmad, V., Perez, G., Garcia, A., Manjunath, Y., Kaifi, J. T., Li, G., & Chabu, C. Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-10598-x · Cited by 42
Application of Microfluidics in Detection of Circulating Tumor Cells
Li, C., He, W., Wang, N., Xi, Z., Deng, R., Liu, X., Kang, R., Xie, L., & Liu, X. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.907232 · Cited by 42
Tumor-Derived Exosomal miR-620 as a Diagnostic Biomarker in Non-Small-Cell Lung Cancer
Tang, Y., Zhang, Z., Song, X., Yu, M., Niu, L., Zhao, Y., Wang, L., Song, X., & Xie, L. (2020) · Journal of Oncology · doi:10.1155/2020/6691211 · Cited by 40
de Kock, R., van den Borne, B., Soud, M. Y.-E., Belderbos, H. N. A., Stege, G., de Saegher, M. E. A., van Dongen-Schrover, C., Genet, S. A. A. M., Brunsveld, L., Scharnhorst, V., et al. (2021) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2021.100410 · Cited by 38
Haverfield, E. V., Esplin, E. D., Aguilar, S. J., Hatchell, K. E., Ormond, K. E., Hanson‐Kahn, A., Atwal, P. S., Macklin‐Mantia, S. K., Hines, S. L., Sak, C. W.-M., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-01999-2 · Cited by 38
Cho, W.-C., Kim, M. J., Park, J. W., Jeong, S., & Ku, J. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.101000 · Cited by 37
Potential diagnostic value of miRNAs in peripheral blood for osteosarcoma: A meta-analysis
Gao, S., Wang, Y., Zhang, G., & Zhang, W. (2020) · Journal of bone oncology · doi:10.1016/j.jbo.2020.100307 · Cited by 35
Early diagnostic and prognostic value of serum exosomal miR-1246 in non-small cell lung cancer.
Huang, D., & Qu, D. (2020) · PubMed Central · Cited by 34
Schienda, J., Church, A. J., Corson, L. B., Decker, B. J., Clinton, C. M., Manning, D. K., Imamović, A., Reidy, D., Strand, G. R., Applebaum, M. A., et al. (2021) · JCO Precision Oncology · doi:10.1200/po.21.00281 · Cited by 34
Youssef, O., Sarhadi, V. K., Armengol, G., Piirilä, P. L., Knuuttila, A., & Knuutila, S. (2016) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22399 · Cited by 33
Self-citationSu, K., Yu, Q., Shen, R., Sun, S., Moreno, C. S., Li, X., & Qin, Z. S. (2020) · Cell Reports Methods · doi:10.1016/j.crmeth.2021.100050 · Cited by 33
Pantano, F., Zalfa, F., Iuliani, M., Simonetti, S., Manca, P., Napolitano, A., Tiberi, S., Russano, M., Citarella, F., Foderaro, S., et al. (2022) · Cancers · doi:10.3390/cancers14102435 · Cited by 33
Liu, Y., Li, R. Q., Zhang, L., & Guo, S. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.850241 · Cited by 31
Janpipatkul, K., Trachu, N., Watcharenwong, P., Panvongsa, W., Worakitchanon, W., Metheetrairut, C., Oranratnachai, S., Reungwetwattana, T., & Chairoungdua, A. (2021) · Cancer Biomarkers · doi:10.3233/cbm-203075 · Cited by 30
Nagel, Z. D., Engelward, B. P., Brenner, D. J., Begley, T. J., Sobol, R. W., Bielas, J. H., Stambrook, P. J., Wei, Q., Hu, J. J., Terry, M. B., et al. (2017) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2017.03.007 · Cited by 29
Immunotherapy Predictive Molecular Markers in Advanced Gastroesophageal Cancer: MSI and Beyond
Park, R., da Silva, L. L., & Saeed, A. (2021) · Cancers · doi:10.3390/cancers13071715 · Cited by 28
Chałubińska‐Fendler, J., Graczyk, Ł., Piotrowski, G., Wyka, K., Nowicka, Z., Tomasik, B., Fijuth, J., Kozono, D., & Fendler, W. M. (2019) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2019.04.002 · Cited by 27
Poon, M. T. C., Keni, S., Vimalan, V., Ip, C. L., Smith, C., Erridge, S., Weir, C. J., & Brennan, P. M. (2021) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdab171 · Cited by 27
Wu, H., Kehm, R. D., Santella, R. M., Brenner, D. J., & Terry, M. B. (2022) · Scientific Reports · doi:10.1038/s41598-022-07256-7 · Cited by 27
Predicting cancer drug TARGETS - TreAtment Response Generalized Elastic-neT Signatures
Rydzewski, N. R., Peterson, E. R., Lang, J. M., Yu, M., Chang, S. L., Sjöström, M., Bakhtiar, H., Song, G., Helzer, K. T., Bootsma, M. L., et al. (2021) · npj Genomic Medicine · doi:10.1038/s41525-021-00239-z · Cited by 26
Diagnostic Potential of Exosomal microRNAs in Colorectal Cancer
Dohmen, J., Semaan, A., Kobilay, M., Zaleski, M., Branchi, V., Schlierf, A., Hettwer, K., Uhlig, S., Hartmann, G., Kalff, J. C., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12061413 · Cited by 24
Nanoribbon-Based Electronic Detection of a Glioma-Associated Circular miRNA
Ivanov, Y. D., Malsagova, K. A., Popov, V. P., Pleshakova, T. O., Kozlov, A. F., Galiullin, R. A., Shumov, I. D., Kapustina, S. I., Tikhonenko, F. V., Ziborov, V. S., et al. (2021) · Biosensors · doi:10.3390/bios11070237 · Cited by 23
Velázquez, C., Lastra, E., Cobos, F. A., Abella, L., de la Cruz, V., Hernando, B., Hernández, L., Martínez, N., Infante, M., & Durán, M. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02391-z · Cited by 22
Khavari, A. P., Liu, Y., He, E., Skog, S., & Haghdoost, S. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/4153574 · Cited by 20
Kaźmierczak, D., Eide, I. J. Z., Gencheva, R., Lai, Y. C., Lewensohn, R., Tsakonas, G., Grundberg, O., Petris, L. D., McGowan, M., Brustugun, O. T., et al. (2022) · Translational Lung Cancer Research · doi:10.21037/tlcr-21-955 · Cited by 20
Precision Medicine and Testing for Tumor Biomarkers—Are All Tests Born Equal?
Hayes, D. F. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.4018 · Cited by 19
Molecular cancer screening: in search of evidence
Raoof, S., Kennedy, C. J., Wallach, D. A., Bitton, A., & Green, R. C. (2021) · Nature Medicine · doi:10.1038/s41591-021-01431-5 · Cited by 19
Bertók, T., Bertóková, A., Jáné, E., Híreš, M., Aguedo, J., Potočárová, M., Lukáč, Ľ., Vikartovská, A., Kasák, P., Borsig, L., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.735338 · Cited by 16
Akras, Z., Bungo, B., Leach, B. H., Marquard, J., Ahluwalia, M. S., Carraway, H. E., Grivas, P. D., Sohal, D. P. S., & Funchain, P. (2019) · JCO Precision Oncology · doi:10.1200/po.18.00258 · Cited by 15
Harnessing genome-wide association studies to minimize adverse radiation-induced side effects
Benitez, C. M., & Knox, S. J. (2020) · Radiation Oncology Journal · doi:10.3857/roj.2020.00556 · Cited by 15
Leonetti, A., Capula, M., Minari, R., Mazzaschi, G., Gregori, A., Hassouni, B. E., Papini, F., Bordi, P., Verzè, M., Avan, A., et al. (2021) · Cells · doi:10.3390/cells10061520 · Cited by 15
Armengol, G., Sarhadi, V. K., Ghanbari, R., Doghaei-Moghaddam, M., Ansari, R., Sotoudeh, M., Puolakkainen, P. A., Kokkola, A., Malekzadeh, R., & Knuutila, S. (2016) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2016.01.008 · Cited by 14
Self-citationNanoribbon Biosensor in the Detection of miRNAs Associated with Colorectal Cancer
Ivanov, Y. D., Goldaeva, K. V., Malsagova, K. A., Pleshakova, T. O., Galiullin, R. A., Popov, V. P., Кушлинский, Н. Е., Alferov, A. A., Enikeev, D. V., Potoldykova, N. V., et al. (2021) · Micromachines · doi:10.3390/mi12121581 · Cited by 13
Mio, C., & Damante, G. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166390 · Cited by 11
State of the art and trends of circulating cancer biomarkers
Gion, M., Trevisiol, C., & Fabricio, A. S. C. (2020) · The International Journal of Biological Markers · doi:10.1177/1724600819900512 · Cited by 10
van Zweeden, A. A., Opperman, R. C. M., Honeywell, R. J., Peters, G. J., Verheul, H. M. W., van der Vliet, H. J., & Poel, D. (2021) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2021.100371 · Cited by 9
Grupińska, J., Budzyń, M., Brzeziński, J., Gryszczyńska, B., Kasprzak, M. P., Kycler, W., Leporowska, E., & Iskra, M. (2021) · Biomedical Reports · doi:10.3892/br.2021.1406 · Cited by 7
CRMarker: A manually curated comprehensive resource of cancer RNA markers
Zhang, J., Yan, S., Li, R., Wang, G., Kang, S., Wang, Y., Hou, W., Wang, C., & Tian, W. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.01.186 · Cited by 5
Can we detect biomarkers of oral squamous cell carcinoma from saliva or mouth swabs?
Gaw, G., & Gribben, M. (2022) · Evidence-Based Dentistry · doi:10.1038/s41432-022-0248-9 · Cited by 4
Cited by
Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells
Garg, P., Malhotra, J., Kulkarni, P., Horne, D., Salgia, R., & Singhal, S. S. (2024) · Cancers · doi:10.3390/cancers16132478 · Cited by 339
“Their predictive abilities empower oncologists to make informed decisions about the best treatment options for each patient [90].”
BackgroundAI-Assisted Detection of Biomarkers by Sensors and Biosensors for Early Diagnosis and Monitoring
Wasilewski, T., Kamysz, W., & Gębicki, J. (2024) · Biosensors · doi:10.3390/bios14070356 · Cited by 290
Digital PCR: From early developments to its future application in clinics
Trouchet, A., Gines, G., Benhaim, L., & Taly, V. (2025) · Lab on a Chip · doi:10.1039/d5lc00055f · Cited by 43
Metadata
- Authors
- Sarhadi, V. K., & Armengol, G.
- Venue
- Biomolecules
- Publisher
- MDPI AG
- Published
- 2022-07-23
- Volume
- 12
- Issue
- 8
- Pages
- 1021
- ISSN
- 2218-273X (ISSN-L)
- OpenAlex
- W4287009981
- Cited by
- 467
- References
- 155
- FWCI
- 33.73
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.